Newsroom 
TERUMO Japan | 中文 | Size Small Big
CaridianBCT and Terumo Transfusion Become Terumo BCT

Company Focuses on Commitment to Blood Banking, Transfusion Medicine and Cellular Therapies

 

LAKEWOOD, Colo.—April 2, 2012—CaridianBCT and Terumo Transfusion have become Terumo BCT. Terumo BCT is one of the largest, U.S.-based medical device companies focused on blood banking, transfusion medicine and cellular therapies.

 

Terumo BCT, a subsidiary of Terumo Corporation, is headquartered in Lakewood, Colorado.President and CEO of CaridianBCT, David Perez, retains his position serving as Terumo BCT ‘s President and CEO. Perez was also named Chairman of Terumo Corporation’s Blood Management Division on May 22, 2011.

 


 
About Terumo BCT:

Terumo BCT, a global leader in blood component and cellular technologies, is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.